Please wait while we open this resource.
K
Clinical reviews
INCLISIRAN: PRESENT AND FUTURE PERSPECTIVES OF A NEW EFFECTIVE LDL CHOLESTEROL-LOWERING AGENT
Graecia University
PDF8 pages818 KB
Inclisiran has recently been approved by regulatory agencies due to its efficacy and safety in treating dyslipidemias. The review discusses the established link between LDL-cholesterol and atherosclerotic cardiovascular disease (ASCVD), emphasizing inclisiran's role as a promising therapeutic tool. It provides insights into ongoing trials and future perspectives for its implementation in clinical practice.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology